FDA Looks To End Athenex's Active Ingredient Suit
The U.S. Food and Drug Administration has urged a federal court to toss Athenex Inc.'s challenge to the agency's finding that there was no clinical need for a drug containing the...To view the full article, register now.
Already a subscriber? Click here to view full article